Beta‐Blocker Therapy for Heart Failure: Should the Therapeutic Target Be Dose or Heart Rate Reduction?

Therapeutic target with β blockers in heart failure, i.e., target heart rate reduction or β‐blocker dose, is controversial. To resolve this controversy, the authors studied 152 heart failure patients on β blockers who were divided into four groups based on median peak exercise heart rate reduction a...

Ausführliche Beschreibung